These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24746414)

  • 1. Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
    Bendas ER; Abdelbary AA
    Int J Pharm; 2014 Jul; 468(1-2):97-104. PubMed ID: 24746414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of HPMC and Eudragit S100 blended microparticles containing sodium pantoprazole.
    Raffin RP; Colomé LM; Haas SE; Jornada DS; Pohlmann AR; Guterres SS
    Pharmazie; 2007 May; 62(5):361-4. PubMed ID: 17557744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole--a new formulation.
    Armstrong D
    Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
    Pandey VP; Phanindrudu A; Manavalan R; Livingston J
    Boll Chim Farm; 2002; 141(6):419-22. PubMed ID: 12577509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-based nanocapsules for drug delivery.
    Mora-Huertas CE; Fessi H; Elaissari A
    Int J Pharm; 2010 Jan; 385(1-2):113-42. PubMed ID: 19825408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.
    Riedel A; Leopold CS
    Drug Dev Ind Pharm; 2005 Jan; 31(2):151-60. PubMed ID: 15773282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation enhances the anti-ulcerogenic properties of Entada africana leaf extract.
    Obidike IC; Emeje MO
    J Ethnopharmacol; 2011 Sep; 137(1):553-61. PubMed ID: 21704690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of enteric microparticles by coacervation.
    Thomas S; Chong YN; Chaw CS
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1142-51. PubMed ID: 23003201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state interactions at the core-coat interface: physicochemical characterization of enteric-coated omeprazole pellets without a protective sub-coat.
    Sharma VD; Akocak S; Ilies MA; Fassihi R
    AAPS PharmSciTech; 2015 Aug; 16(4):934-43. PubMed ID: 25595125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles.
    Raffin RP; Colomé LM; Pohlmann AR; Guterres SS
    Eur J Pharm Biopharm; 2006 Jun; 63(2):198-204. PubMed ID: 16531029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
    He W; Fan LF; Du Q; Xiang B; Li CL; Bai M; Chang YZ; Cao DY
    Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):122-8. PubMed ID: 19182399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
    Lai X; Sun C; Tian H; Zhao W; Gao L
    Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of enteric submicron particle formulation of papain for oral delivery.
    Sharma M; Sharma V; Panda AK; Majumdar DK
    Int J Nanomedicine; 2011; 6():2097-111. PubMed ID: 22114474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.
    Stroyer A; McGinity JW; Leopold CS
    J Pharm Sci; 2006 Jun; 95(6):1342-53. PubMed ID: 16625655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
    Taha MM; Salga MS; Ali HM; Abdulla MA; Abdelwahab SI; Hadi AH
    J Ethnopharmacol; 2012 May; 141(1):273-81. PubMed ID: 22374081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of capsules containing omeprazole in enteric coated pellets.
    Palummo M; Cingolani A; Dall L; Volonté MG
    Boll Chim Farm; 2000; 139(3):124-8. PubMed ID: 10961022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.